Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
7.35
+0.01 (0.14%)
At close: Nov 19, 2026, 4:00 PM EST
7.41
+0.06 (0.82%)
After-hours: Nov 19, 2026, 7:56 PM EST
Kura Oncology Revenue
Kura Oncology had revenue of $22.84M in the quarter ending September 30, 2026, with 10.07% growth. This brings the company's total for the last twelve months to $79.31M, down -23.76% year-over-year. In the year 2025, Kura Oncology had annual revenue of $67.48M with 25.24% growth. That makes Kura Oncology the 24,535th largest company in the world by revenue and 3,445th in the United States.
Revenue (ttm)
$79.31M
Revenue Growth
-23.76%
P/S Ratio
8.51
Revenue / Employee
$305,054
Employees
260
Market Cap
675.31M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 67.48M | 13.60M | 25.24% |
| Dec 31, 2024 | 53.88M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Apnimed | 108.80M |
| Janux Therapeutics | 23.29M |
| Iambic Therapeutics | 18.25M |
| Prime Medicine | 7.06M |
| Attovia Therapeutics | 1.44M |
KURA News
- 1 day ago - Kura Oncology Transcript: Jefferies Global Healthcare Conference - Transcripts
- 2 days ago - Kura Oncology Transcript: UBS Global Biopharma Conference 2026 - Transcripts
- 6 days ago - Kura Oncology to Participate in Two Investor Conferences in November - GlobeNewsWire
- 9 days ago - Kura Oncology files automatic mixed securities shelf - TheFly
- 9 days ago - Kura Oncology Earnings Call Transcript: Q3 2026 - Transcripts
- 9 days ago - Kura Oncology Earnings release: Q3 2026 - Filings
- 9 days ago - Kura Oncology Quarterly report: Q3 2026 - Filings
- 9 days ago - Kura Oncology Slides: Q3 2026 - Filings